Bedaquiline | Requirements for countries | Delamanid |
400 mg per day for 2 weeks then 200 mg three times a week for 22 weeks Pharmacovigilance Informed consent QT monitoring | Country preparedness and planning National plan new tools Monitoring and evaluation (drug-resistance surveillance and pharmacovigilance) Private sector engaged Uninterrupted supply Operational research | 100 mg two times a day for 6 or 12 months added to OBR in adults Pharmacovigilance Informed consent Not added to bedaquiline |